Use of remifentanil in an infant with surgically repaired Shone's syndrome

A G Tsiotou1, P Matsota, E Kouptsova

  • 1Department of Anesthesiology, Children's Hospital P. & A. Kyriakou, Athens, Greece. georgesakorafas@yahoo.com

Insights

Remifentanil, an anesthetic, was used in an infant with Shone's syndrome and clubfoot. Its unique properties suggest it may be a predictable option for high-risk pediatric patients.

Area of Science:

  • Anesthesiology
  • Pediatric Cardiology
  • Orthopedic Surgery

Background:

  • Shone's syndrome is a rare congenital heart defect.
  • Congenital clubfoot is a common orthopedic condition in infants.
  • Management of anesthesia in infants with complex comorbidities presents challenges.

Observation:

  • A case study involving an infant with partially repaired Shone's syndrome and congenital clubfoot.
  • The infant required tendon lengthening surgery for clubfoot.
  • Remifentanil was administered for anesthesia during the procedure.

Findings:

  • Remifentanil demonstrated unique pharmacokinetic properties.
  • Its use was predictable in this infant with significant comorbidities.
  • Successful anesthetic management was achieved, facilitating the orthopedic procedure.

Implications:

  • Remifentanil may be a valuable anesthetic agent for infants with complex congenital conditions.
  • This case highlights the potential utility of remifentanil in pediatric patients with multiple comorbidities.
  • Further research could explore the broader application of remifentanil in high-risk pediatric surgical cases.